More information is available on the use of HMDP in the ASNC and EANM Cardiac Amyloidosis Practice Points
The purpose of this document is to identify the critical components involved in performing 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) or 99mTechnetium-hydroxymethylene diphosphonate (99mTc-HMDP) imaging for the evaluation of cardiac transthyretin amyloidosis (ATTR).
Resource Type
Practice Points
Clinical Topic
Cardiac Amyloidosis
Year Published
2019
Related Resources
Posters
Think Amyloid Optimizing Imaging with Tc-99m HMDP_HDP and Tc-99m PYP for Transthyretin Cardiac Amyloidosis Poster
Download now to display in your lab! You may purchase a printed…
Posters
Think Amyloid Multimodality Imaging in the Diagnosis of ATTR-CM Poster
Download now to display in your lab! You may purchase a printed…
ASNC Quality Metrics for Cardiac Amyloid Radionuclide Imaging – 2024
ASNC released a new document defining quality standards for cardiac amyloid radionuclide…
